Synagis 50Mg - 1 Fa C/0,5Ml
SYNAGIS is a powdered lyophilized formulation for injectable solution containing 50 mg per vial, used for preventing respiratory syncytial virus (RSV) infection in high-risk infants and children.
- The description claims that SYNAGIS is contraindicated in cases of known hypersensitivity to palivizumabe or any component of the formula.
AI Readiness
Good foundation, but some important product data is still missing.
80%